# Clinical Trials and Breakthrough Treatments with Michael Banov, MD Page: https://stenobird.com/podcast/psychiatry-tomorrow-6379352/clinical-trials-and-breakthrough-treatments-with-michael-banov-md Text version: https://stenobird.com/podcast/psychiatry-tomorrow-6379352/clinical-trials-and-breakthrough-treatments-with-michael-banov-md.md Podcast: [Psychiatry Tomorrow](https://stenobird.com/podcast/psychiatry-tomorrow-6379352) Published: 2024-01-10T15:00:00+00:00 Episode link: https://psychiatry-tomorrow.simplecast.com/episodes/clinical-trials-and-breakthrough-treatments-with-michael-banov-md-G2vRXwzi Audio file: https://cdn.simplecast.com/audio/7c4e7234-fd4f-46db-ab02-6c8ac13c0a6a/episodes/6a843251-e45c-4ff6-9308-e7f714abf18a/audio/cb8cc81a-f158-4219-a7da-6a9a16146954/default_tc.mp3?aid=rss_feed&feed=oh4b3Jfb Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/psychiatry-tomorrow-6379352/episodes/clinical-trials-and-breakthrough-treatments-with-michael-banov-md Duration seconds: 3049 ## Resource Dive into the riveting world of psychiatric clinical trials with Dr. Michael Banov, a triple-board certified expert with over 150 trials under his belt. From the pioneering Clozapine trial to the latest in Vagus Nerve Stimulators, discover the evolution, challenges, and ethical nuances of these groundbreaking studies. ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/psychiatry-tomorrow-6379352/episodes/clinical-trials-and-breakthrough-treatments-with-michael-banov-md/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/psychiatry-tomorrow-6379352/clinical-trials-and-breakthrough-treatments-with-michael-banov-md.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.